Beech Hill Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
33,594
+208
+0.6% +$19.9K 1.46% 26
2025
Q4
$3.21M Sell
33,386
-893
-3% -$86.7K 1.54% 25
2025
Q3
$3.26M Sell
34,279
-3,103
-8% -$285K 1.52% 26
2025
Q2
$3.26M Sell
37,382
-10,418
-22% -$884K 1.47% 24
2025
Q1
$4.3M Sell
47,800
-506
-1% -$45.3K 1.71% 17
2024
Q4
$3.86M Buy
48,306
+2,519
+6% +$218K 1.44% 26
2024
Q3
$4.12M Sell
45,787
-418
-0.9% -$35.2K 1.56% 20
2024
Q2
$3.64M Buy
46,205
+113
+0.2% +$9.26K 1.5% 25
2024
Q1
$4.02M Sell
46,092
-172
-0.4% -$14.7K 1.67% 19
2023
Q4
$3.81M Sell
46,264
-1,906
-4% -$145K 1.84% 18
2023
Q3
$3.77M Buy
48,170
+98
+0.2% +$8.2K 1.9% 15
2023
Q2
$4.24M Buy
48,072
+242
+0.5% +$20.8K 2.06% 16
2023
Q1
$3.86M Buy
+47,830
New +$3.9M 1.94% 20

Other funds holding MDT

Beech Hill Advisors's MDT Position: Q1 2026 in Review

Beech Hill Advisors increased its Medtronic (MDT) stake by 0.62% in Q1 2026, buying an estimated $19.9K and bringing the position to 33,594 shares worth $2.91M. The position accounts for 1.46% of the portfolio, ranked #26.

Beech Hill Advisors first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.3M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Beech Hill Advisors held 33,594 shares of Medtronic worth $2.91M as of Q1 2026.
  • Beech Hill Advisors bought 208 Medtronic shares in Q1 2026, an estimated $19.9K.
  • Medtronic made up 1.46% of Beech Hill Advisors's portfolio in Q1 2026, its #26 holding.
  • Beech Hill Advisors first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
  • Beech Hill Advisors's Medtronic position peaked at $4.3M in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Beech Hill Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.